首页> 外国专利> 2 - 3 - (2,2-difluorobenzo-benzene 1,3 dioxo-5-ethylamine) - 5 - (2,6-dimethylpyridine-4-il) - 1,2,4 triazole-1-il - n-acetyl-acetyl and its salts as modulators of α - nicotine receptor

2 - 3 - (2,2-difluorobenzo-benzene 1,3 dioxo-5-ethylamine) - 5 - (2,6-dimethylpyridine-4-il) - 1,2,4 triazole-1-il - n-acetyl-acetyl and its salts as modulators of α - nicotine receptor

机译:2-[3-(2,2-二氟苯并苯[1,3]二氧-5-乙胺)-5-(2,6-二甲基吡啶-4-il)-[1,2,4]三唑-1- [il]-n-乙酰基-乙酰基及其盐作为α-尼古丁受体的调节剂

摘要

For compounds 2 - [3 - (2,2-difluorobenzo [1,3] dioxo-5-ethylmethyl) - 5 - (2,6-dimethyl-pyridine-4-il) - [1,2,4] triazole-1-il] - n-ethyl-acetyl-n (I),Salts, hydrates and solutions. A preparation procedure and a drug synthesis were also mentioned. This compound is a Western Sahara modulator positive for acetylcholine A-7 nicotine receptor, which is useful in the treatment of Alzheimer's disease, Lewy's body dementia, Parkinson's disease, etc.
机译:对于化合物2-[3-(2,2-二氟苯并[1,3]二氧-5-乙基甲基)-5-(2,6-二甲基吡啶-4-il)-[1,2,4]三唑- 1-il]-n-乙基-乙酰基-n(I),盐,水合物和溶液。还提到了制备步骤和药物合成。该化合物是对乙酰胆碱A-7烟碱受体呈阳性的Western Sahara调节剂,可用于治疗阿尔茨海默氏病,路易氏体痴呆,帕金森氏症等。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号